Position in CERS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$72,681
+$26,931 QoQ
Shares Held
39,935
+79.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026EntryPoint Capital, LLC holds $2,870,811 across 12 Medical Devices names. CERS ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
1,326 | $435,710 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
5,208 | $370,705 | |
| 3 | BSX |
Boston Scientific Corp
|
5,405 | $339,163 | |
| 4 | AXGN |
Axogen, Inc.
|
7,336 | $243,041 | |
| 5 | AORT |
Artivion, Inc.
|
6,620 | $242,424 | |
| 6 | SNN |
Smith & Nephew PLC
|
7,619 | $242,131 | |
| 7 | DCTH |
Delcath Systems, Inc.
|
25,030 | $232,278 | |
| 8 | EW |
Edwards Lifesciences Corp
|
2,761 | $221,100 |
All Filings in CERS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $72,681 | 39,935 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $45,750 | 22,209 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $260,494 | 163,833 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $189,379 | 134,312 | Shares | Sole | 2025-08-11 | |
| 2024-12-31 | $184,764 | 119,977 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $141,288 | 81,200 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $109,175 | 57,765 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $41,260 | 19,102 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||